Medical Products Supplies Companies

Science Park CREALYS Rue Jean Sonet 4 A, 5032 Gembloux
Belgium
Telephone +32 81 719914
Fax +32 81 719919
info@corisbio.com
http://www.corisbio.com

Product Categories

Product categories

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.02 Diagnostic rapid tests

Diagnostic rapid tests

OXA-23
BL-RED 25
RESIST-5 O.O.K.N.V.

Our products

Product category: Diagnostic rapid tests
OXA-23
Rapid diagnostic test for in vitro identification of Carbapenemase OXA-23-like in bacteria culture.OXA-23 is the brand new RESIST test from Coris BioConcept.

It was developed in collaboration with the Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne.

PerformancesThe OXA-23 K-SeT was evaluated on a collection of 108 clinical isolates with fully characterized resistance mechanisms to beta-lactams by phenotypic and molecular tests (Germany).

This collection included 73 isolates with various resistance mechanisms including 5 class B carbapenemases (NDM and VIM) and 68 isolates from five others OXA-subgroups associated with carbapenem-resistance in A. baumannii: the intrinsic OXA-51-like, OXA-58-like, OXA-40-like, OXA-143-like and OXA-235-like (100% specificity).

All 35 OXA-23 like CPE strains whatever the allelic variant gave a positive signal for OXA-23 with the cassette OXA-23 K-SeT (100% sensitivity).

Product category: Diagnostic rapid tests
BL-RED 25
Electrochemical in vitro rapid detection test of resistance to third-generation cephalosporins by hydrolysis.The BL-RED test delivers a fast and objective result on the 3GC hydrolysis profile of Enterobacteriaceae strains. Used as a front-line test, BL-RED is foreseen as the ideal tool to accelerate decision on the antimicrobial prescription.

Advantages of the kits• Only 2 minutes hands-on-time
• Easy to use
• Automated objective results
• Traceability of results
• Compatibility with Mac Conkey, Mueller Hinton, Blood Agar, Positive Blood Culture

Product category: Diagnostic rapid tests
RESIST-5 O.O.K.N.V.
This new immunochromatography test, made of two cassettes, allows the identification of OXA-48-like, OXA-163, KPC, NDM and VIM carbapenemases on cultures.

PerformancesHigh performances compared to PCR :

Sensitivity
allows the identification of OXA-48-like, OXA-163, KPC, NDM and VIM carbapenemases on cultures.
Advantages of the kits
• 1 unique test to detect the 5 main clinically-relevant carbapenemases
• No equipment required
• Easy and ready to use
• Shortest Time-To-Result
• Adopted by many laboratories and reference centers

ad: contact information

About Us

Company details
Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory and gastro-enteric infectious pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres. These rapid tests are extensively used in microbiology laboratories worldwide.To complement this extensive range of fast and accurate lateral flow tests, the company has developed an innovative automated platform that performs multiplex PCR amplification and detection on a microfluidic cartridge (TRAPIST® system). This molecular multiplex platform allows syndromic diagnostic approaches for the clinical management of main human infections and resistance to antibiotics.

Coris BioConcept provides services for custom tests development and contract manufacturing. The company is present in more than 60 countries in Europe, Asia, South America, Africa and Oceania.

Coris BioConcept is continually involved in collaborative projects with Belgian and European Research Institutes, laboratories and companies for the development of breaking new solutions.

All Coris BioConcept’s products fulfil the CE marking requirements and the company is also ISO 13485 certified.

Our Quality Management System is covering “Design, development, manufacture and distribution of in vitro diagnostic devices for the detection of pathogens in the diagnosis of respiratory, gastric, enteric and parasitic diseases, the detection of resistance to antibiotics and the detection in urine of therapeutics, used for the treatment of these infectious diseases”.

ad: company